35956202|t|Comparison of the Effects of Esketamine/Propofol and Sufentanil/Propofol on the Incidence of Intraoperative Hypoxemia during Bronchoscopy: Protocol for a Randomized, Prospective, Parallel-Group Trial.
35956202|a|BACKGROUND: Propofol, ketamine, and sufentanil are the most commonly used anesthetics during bronchoscopy, alone or in combination, for sedation. Esketamine is an s-enantiomer of ketamine racemate and has both sedative and analgesic effects. Esketamine does not inhibit respiration and maintains hemodynamic stability. This study aims to compare the clinical efficacy of esketamine/propofol with sufentanil/propofol for patients during bronchoscopy. METHODS: Patients undergoing bronchoscopy will be randomly assigned to receive either sufentanil/propofol (sufentanil group; n = 33; sufentanil: 0.2 mug/kg) or esketamine/propofol (esketamine group; n = 33; esketamine: 0.2 mg/kg) for sedation and analgesia. Intraoperative clinical information, general anesthetic drug dosage, the incidence of intraoperative hypoxemia, total time of hypoxemia, awakening time, delirium, nausea and vomiting, adverse reactions, and patient satisfaction will be collected. DISCUSSION: Hypoxia has detrimental effects on patients with respiratory disease. Ameliorating hypoxemia in patients undergoing bronchoscopy is critical. Our results will provide effective sedation with esketamine in patients undergoing bronchoscopy. TRIAL REGISTRATION: Chinese clinical trial registry: ChiCTR2200058990.
35956202	29	39	Esketamine	Chemical	MESH:C000629870
35956202	40	48	Propofol	Chemical	MESH:D015742
35956202	53	63	Sufentanil	Chemical	MESH:D017409
35956202	64	72	Propofol	Chemical	MESH:D015742
35956202	108	117	Hypoxemia	Disease	MESH:D000860
35956202	213	221	Propofol	Chemical	MESH:D015742
35956202	223	231	ketamine	Chemical	MESH:C000629870
35956202	237	247	sufentanil	Chemical	MESH:D017409
35956202	347	357	Esketamine	Chemical	MESH:C000629870
35956202	380	397	ketamine racemate	Chemical	-
35956202	443	453	Esketamine	Chemical	MESH:C000629870
35956202	572	582	esketamine	Chemical	MESH:C000629870
35956202	583	591	propofol	Chemical	MESH:D015742
35956202	597	607	sufentanil	Chemical	MESH:D017409
35956202	608	616	propofol	Chemical	MESH:D015742
35956202	621	629	patients	Species	9606
35956202	660	668	Patients	Species	9606
35956202	737	747	sufentanil	Chemical	MESH:D017409
35956202	748	756	propofol	Chemical	MESH:D015742
35956202	758	768	sufentanil	Chemical	MESH:D017409
35956202	784	794	sufentanil	Chemical	MESH:D017409
35956202	811	821	esketamine	Chemical	MESH:C000629870
35956202	822	830	propofol	Chemical	MESH:D015742
35956202	832	842	esketamine	Chemical	MESH:C000629870
35956202	858	868	esketamine	Chemical	MESH:C000629870
35956202	1010	1019	hypoxemia	Disease	MESH:D000860
35956202	1035	1044	hypoxemia	Disease	MESH:D000860
35956202	1062	1070	delirium	Disease	MESH:D003693
35956202	1072	1091	nausea and vomiting	Disease	MESH:D020250
35956202	1116	1123	patient	Species	9606
35956202	1168	1175	Hypoxia	Disease	MESH:D000860
35956202	1203	1211	patients	Species	9606
35956202	1217	1236	respiratory disease	Disease	MESH:D012140
35956202	1251	1260	hypoxemia	Disease	MESH:D000860
35956202	1264	1272	patients	Species	9606
35956202	1359	1369	esketamine	Chemical	MESH:C000629870
35956202	1373	1381	patients	Species	9606
35956202	Negative_Correlation	MESH:D017409	MESH:D000860
35956202	Positive_Correlation	MESH:C000629870	MESH:D020250
35956202	Cotreatment	MESH:D015742	MESH:D017409
35956202	Cotreatment	MESH:C000629870	MESH:D015742
35956202	Comparison	MESH:C000629870	MESH:D017409
35956202	Negative_Correlation	MESH:C000629870	MESH:D000860

